Pulmonary Vascular Resistance (PVR) Late after Heart Transplant in Patients with Higher Preoperative Pulmonary Hypertension and Influence on Survival-A Study from India
{"title":"Pulmonary Vascular Resistance (PVR) Late after Heart Transplant in Patients with Higher Preoperative Pulmonary Hypertension and Influence on Survival-A Study from India","authors":"Ratnagiri Ravi Kumar","doi":"10.19080/jocct.2019.13.555855","DOIUrl":null,"url":null,"abstract":"We studied 12 Patients who underwent Successful heart Transplant with High Pre-operative Pulmonary pressures – defined as PA systolic pressure more than 50 mm Hg but with Transpulmonary Gradient less than 16 mm hg after Vasodilator testing, for analysis of Pulmonary heamodynamic parameters like Pulmonary Vascular Resistance, (PVR) and Pulmonary Compliance(Pca) early (one month) and one Year after Heart Transplantation along with Survival at 6 months and one year. These 12 patients were statistically compared with 25 patients who had preoperative PA systolic pressures less than 50mm hg 11 of above patients were on both Sildenefil and Ambrisentan for PAH [1].","PeriodicalId":73635,"journal":{"name":"Journal of cardiology & cardiovascular therapy","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology & cardiovascular therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/jocct.2019.13.555855","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
We studied 12 Patients who underwent Successful heart Transplant with High Pre-operative Pulmonary pressures – defined as PA systolic pressure more than 50 mm Hg but with Transpulmonary Gradient less than 16 mm hg after Vasodilator testing, for analysis of Pulmonary heamodynamic parameters like Pulmonary Vascular Resistance, (PVR) and Pulmonary Compliance(Pca) early (one month) and one Year after Heart Transplantation along with Survival at 6 months and one year. These 12 patients were statistically compared with 25 patients who had preoperative PA systolic pressures less than 50mm hg 11 of above patients were on both Sildenefil and Ambrisentan for PAH [1].
我们研究了12名成功接受心脏移植且术前肺高压(定义为PA收缩压大于50 mm Hg,但经肺梯度小于16 mm Hg)的患者,用于分析肺血流动力学参数,如肺血管阻力,(PVR)和肺顺应性(Pca),以及6个月和1年的存活率。将这12名患者与25名术前PA收缩压小于50mmhg的患者进行统计学比较,其中11名患者同时服用西地那非和安必生坦治疗PAH[1]。